资讯
6 天on MSN
The US Food and Drug Administration has delayed granting full approval of Novavax’s Covid-19 vaccine despite it being on ...
导语: 2025 年 4 月,美国食品药品监督管理局(FDA)未能按期完成对 Novavax 公司针对 JN.1 变种的新冠疫苗审查,距 CBER 主任 Peter Marks 因疫苗政策分歧辞职仅过去三天。这场审批延误不仅暴露 FDA ...
在新政府的更迭之下,美国食品药品监督管理局(FDA)正经历着一场前所未有的高层人事动荡。自唐纳德・特朗普再次就职以及罗伯特・F・肯尼迪(Robert F. Kennedy Jr.)执掌美国卫生与公众服务部(HHS)以来,FDA ...
The U.S. Food and Drug Administration has missed its deadline for making a decision on traditional approval for Novavax's ...
The U.S. Food and Drug Administration has missed the deadline for making a decision on Novavax's COVID-19 vaccine, a source ...
Concern is growing among public health experts that anti-vaccine sentiments within federal and state governments may derail ...
美国食品药物管理局(FDA)负责疫苗和其他生物药品审批的Peter Marks据报被迫辞职,Moderna(MRNA.US)等疫苗生产商股价暴跌。
The delay dovetails with moves by Republican lawmakers in at least seven states to ban or limit mRNA vaccines. Some, according to KFF Health News, are also pressing regulators to revoke federal ...
Health and Me on MSN3 天
FDA Delays Approval Of Novavax COVID-19 VaccineThe delay follows leadership changes within the FDA. Dr. Scott Steele has been appointed acting director of the agency’s ...
The agency is sitting on a decision to grant full approval for Novavax’s shot, days after top vaccine regulator pushed out.
The FDA was supposed to make a final decision about approval of Novavax's COVID-19 vaccine this week, but that deadline has ...
The FDA delays full approval for Novavax's COVID-19 vaccine, citing the need for additional data. Read more here.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果